Industry News
Mesoblast MPCs to be trialled in end-stage heart failure
Mesoblast and the US National Institutes of Health will team up for a 120-patient trial of the company's MPCs in end-stage heart failure. [ + ]
$200 million to boost dementia research
The National Health and Medical Research Council (NHMRC) today announced the first steps in its delivery of the Australian Government's $200 million 'Boosting Dementia Research' budget measure. [ + ]
2014 Eureka Prize finalists
Finalists across the spectrum of life sciences, from research in agriculture and infectious diseases to science journalism and photography, have been announced for the 2014 Australian Museum Eureka Prizes. [ + ]
Priorities for Antarctic research outlined
The Scientific Committee on Antarctic Research (SCAR) has convened 75 scientists and policymakers from 22 countries to agree on the priorities for Antarctic research for the next 20 years and beyond. [ + ]
Process shows potential for graphene scale-up
The future looks bright for the use of graphene in the mass production of biocompatible sensor devices with the development of a new microfabrication process. [ + ]
AusBiotech submits to Senate Inquiry into Australia's Innovation System
AusBiotech's substantive submission to the Senate Standing Committee on Economics' Australian Innovation System inquiry has called for tax reform, support for commercialisation, incentives for commercial thinking and clinical trial reform. [ + ]
Immuron's Travelan launches in Canada
Immuron's (ASX:IMC) distribution partner Paladin Labs has launched OTC travellers' diarrhoea treatment Travelan in Canada. [ + ]
New malaria vaccine approach attracts collaboration
A collaboration between the Burnet Institute and ARTES Biotechnology will progress the development of and test a new strategy for a malaria vaccine. [ + ]
AOD9604 awarded safe status in US
Calzada (ASX:CZD) said its peptide AOD9604 has secured Generally Recognised As Safe status in the US, allowing its use in food and supplements at a daily level of up to 1 mg per person. [ + ]
Advancing research in plant energy biology
The launch of the Australian Research Council Centre of Excellence in Plant Energy Biology 2014-2020, will focus on understanding and enhancing plant energy systems to increase crop yields. [ + ]
RV Investigator en route to Hobart
The CSIRO research vessel Investigator is setting sail from Singapore for its new home port of Hobart, where it is expected to arrive by mid-September. The vessel's arrival, which was initially planned for June 2013, will enable the Marine National Facility (MNF) Steering Committee to determine its 2014-15, 2015-16 and 2016-17 voyage scheduling. [ + ]
Baxter to sell vaccine business to Pfizer
Healthcare company Baxter International has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to pharmaceutical company Pfizer for a total cash consideration of $635 million, subject to certain adjustments. [ + ]
ResMed Q4 net grows 20% despite weak Americas sales
ResMed (ASX:RMD) has reported a 20% growth in profit but flat revenue for the fourth quarter, and reported the results of a successful study into using NPPH to treat advanced COPD. [ + ]
Nominate Australia's biotech leaders for this year's Industry Excellence Awards
Who do you think are the industry's high achievers? The annual Industry Excellence Awards celebrate the individuals and organisations that have made a significant contribution to the biotechnology industry and, through their leadership, continue to make a difference to the growth of the bio-economy. The recipients of these prestigious awards are at the forefront of thriving biotech, innovation and healthcare sectors in Australia. [ + ]
US doctors using Osprey's AVERT in PAD
US physicians have identified a potential new market for Osprey's AVERT system, which is designed to help protect the kidneys from toxic dyes used in X-ray imaging. [ + ]
